MEDS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MEDS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Trxade Health's Average Total Inventories for the three months ended in Dec. 2023 was $1.51 Mil. Trxade Health's Cost of Goods Sold for the three months ended in Dec. 2023 was $4.60 Mil. Hence, Trxade Health's Days Inventory for the three months ended in Dec. 2023 was 30.03.
The historical rank and industry rank for Trxade Health's Days Inventory or its related term are showing as below:
During the past 13 years, Trxade Health's highest Days Inventory was 88.37. The lowest was 2.16. And the median was 28.97.
Trxade Health's Days Inventory increased from Dec. 2022 (8.77) to Dec. 2023 (30.03). It might indicate that Trxade Health's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year. Trxade Health's Inventory Turnover for the three months ended in Dec. 2023 was 3.04.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Trxade Health's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.64.
The historical data trend for Trxade Health's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trxade Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 9.75 | 21.02 | 46.63 | 4.71 | 2.16 |
Trxade Health Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 8.77 | 12.68 | 21.61 | 412.05 | 30.03 |
For the Pharmaceutical Retailers subindustry, Trxade Health's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Trxade Health's Days Inventory distribution charts can be found below:
* The bar in red indicates where Trxade Health's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Trxade Health's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (0.066 | + | 0.001) | / | 2 ) | / | 5.674 | * | 365 |
= | 0.0335 | / | 5.674 | * | 365 | ||||
= | 2.16 |
Trxade Health's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (3.027 | + | 0.001) | / | 2 ) | / | 4.601 | * | 365 / 4 |
= | 1.514 | / | 4.601 | * | 365 / 4 | ||||
= | 30.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trxade Health (NAS:MEDS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Trxade Health's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 4.601 | / | 1.514 | |
= | 3.04 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Trxade Health's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 1.514 | / | 2.352 | |
= | 0.64 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Trxade Health's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
A. Jeffrey Newell | director | 645 CAMP DIXIE RD, PASCOAG RI 02859 |
Donald G. Fell | director | 17537 DARBY LANE, LUTZ FL 33558 |
Janet Huffman | officer: CFO, PAO, PFO | 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232 |
Michael L Peterson | director | 17 CANARY COURT, DANVILLE CA 94526 |
Christine L. Jennings | director | 3840 LAND O' LAKES BLVD., LAND O' LAKES FL 34639 |
Prashant Patel | director, 10 percent owner, officer: President | 17537 DARBY LANE, LUTZ FL 33558 |
Pamela Tenaerts | director | PO BOX 15012, SARASOTA FL 34277 |
Gary Augusta | director | 700 NORTH BRAND BLVD., SUITE 1400, GLENDALE CA 91203 |
Howard A. Doss | officer: CFO | 17537 DARBY LANE, LUTZ FL 90067 |
Surendra K Ajjarapu | director, 10 percent owner, officer: CEO | 8604 BUTTON BUSH CT, TAMPA FL 33647 |
Donald V. Almeida | director | 1115 GUNN HIGHWAY, SUITE 202, ODESSA FL 33556 |
Charles L Pope | director | 4902 EISENHOWER BOULEVARD, TAMPA FL 33634 |
Sandhya Ajjarapu | 10 percent owner | 17537 DARBY LANE, LUTZ FL 33558 |
From GuruFocus
By Marketwired • 06-30-2023
By Marketwired • 08-03-2023
By ACCESSWIRE • 09-07-2023
By Marketwired • 08-24-2023
By Marketwired • 06-23-2023
By ACCESSWIRE ACCESSWIRE • 10-24-2022
By Marketwired • 10-04-2023
By GlobeNewswire • 07-14-2023
By Marketwired • 07-14-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.